Dr Stephen G Andrus, MD | |
210 Westchester Ave, White Plains, NY 10604-2901 | |
(914) 681-3110 | |
(914) 682-6403 |
Full Name | Dr Stephen G Andrus |
---|---|
Gender | Male |
Speciality | Physical Medicine And Rehabilitation |
Experience | 27 Years |
Location | 210 Westchester Ave, White Plains, New York |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1518930825 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208100000X | Physical Medicine & Rehabilitation | 208262 (New York) | Primary |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Westchester Medical Group Pc | 6406752963 | 405 |
News Archive
Arena Pharmaceuticals, Inc. announced today that its New Drug Application (NDA) for lorcaserin, Arena's internally discovered and developed drug candidate for weight management, including weight loss and maintenance of weight loss, has been accepted for filing by the US Food and Drug Administration (FDA). Arena submitted the lorcaserin NDA on December 22, 2009, and expects to learn the Prescription Drug User Fee Act (PDUFA) date in the next few weeks. The PDUFA date is the target date for the FDA to complete its review of an NDA.
BBMRI-LPC (Biobanking and Biomolecular Research Infrastructure - Large Prospective Cohorts) EU infrastructure project was implemented during the years 2013 - 2017. The main findings of this work have now been published in the New Biotechnology journal.
"Decades of war, neglect, and lack of development have left South Sudan with nine out of 10 of th[e] key neglected tropical diseases [NTDs] - all but Chagas disease, which is endemic to South America," and health workers in the new nation are hoping that the recent formation of a large public-private partnership to combat the diseases "will finally help to have an impact on South Sudan's appalling health indicators," IRIN reports.
SFC Fluidics, LLC recently announced it has received a contract for approximately $5 million from the Congressionally Directed Medical Research Program for development of a handheld device for rapid diagnosis of traumatic brain injury (TBI). More than 1.5 million Americans suffer head injuries each year, and TBI has become a signature injury for American troops serving in the wars in Iraq and Afghanistan.
› Verified 7 days ago
Entity Name | Westchester Medical Group Pc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1881653822 PECOS PAC ID: 6406752963 Enrollment ID: O20031208000533 |
News Archive
Arena Pharmaceuticals, Inc. announced today that its New Drug Application (NDA) for lorcaserin, Arena's internally discovered and developed drug candidate for weight management, including weight loss and maintenance of weight loss, has been accepted for filing by the US Food and Drug Administration (FDA). Arena submitted the lorcaserin NDA on December 22, 2009, and expects to learn the Prescription Drug User Fee Act (PDUFA) date in the next few weeks. The PDUFA date is the target date for the FDA to complete its review of an NDA.
BBMRI-LPC (Biobanking and Biomolecular Research Infrastructure - Large Prospective Cohorts) EU infrastructure project was implemented during the years 2013 - 2017. The main findings of this work have now been published in the New Biotechnology journal.
"Decades of war, neglect, and lack of development have left South Sudan with nine out of 10 of th[e] key neglected tropical diseases [NTDs] - all but Chagas disease, which is endemic to South America," and health workers in the new nation are hoping that the recent formation of a large public-private partnership to combat the diseases "will finally help to have an impact on South Sudan's appalling health indicators," IRIN reports.
SFC Fluidics, LLC recently announced it has received a contract for approximately $5 million from the Congressionally Directed Medical Research Program for development of a handheld device for rapid diagnosis of traumatic brain injury (TBI). More than 1.5 million Americans suffer head injuries each year, and TBI has become a signature injury for American troops serving in the wars in Iraq and Afghanistan.
› Verified 7 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Stephen G Andrus, MD 210 Westchester Ave, White Plains, NY 10604-2901 Ph: (914) 749-7000 | Dr Stephen G Andrus, MD 210 Westchester Ave, White Plains, NY 10604-2901 Ph: (914) 681-3110 |
News Archive
Arena Pharmaceuticals, Inc. announced today that its New Drug Application (NDA) for lorcaserin, Arena's internally discovered and developed drug candidate for weight management, including weight loss and maintenance of weight loss, has been accepted for filing by the US Food and Drug Administration (FDA). Arena submitted the lorcaserin NDA on December 22, 2009, and expects to learn the Prescription Drug User Fee Act (PDUFA) date in the next few weeks. The PDUFA date is the target date for the FDA to complete its review of an NDA.
BBMRI-LPC (Biobanking and Biomolecular Research Infrastructure - Large Prospective Cohorts) EU infrastructure project was implemented during the years 2013 - 2017. The main findings of this work have now been published in the New Biotechnology journal.
"Decades of war, neglect, and lack of development have left South Sudan with nine out of 10 of th[e] key neglected tropical diseases [NTDs] - all but Chagas disease, which is endemic to South America," and health workers in the new nation are hoping that the recent formation of a large public-private partnership to combat the diseases "will finally help to have an impact on South Sudan's appalling health indicators," IRIN reports.
SFC Fluidics, LLC recently announced it has received a contract for approximately $5 million from the Congressionally Directed Medical Research Program for development of a handheld device for rapid diagnosis of traumatic brain injury (TBI). More than 1.5 million Americans suffer head injuries each year, and TBI has become a signature injury for American troops serving in the wars in Iraq and Afghanistan.
› Verified 7 days ago
Lata D Bhansali, M. D. Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 176 Grand St, White Plains, NY 10601 Phone: 914-328-6080 Fax: 914-328-6081 | |
Dr. Jason Georgekutty, D.O. Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 785 Mamaroneck Ave, White Plains, NY 10605 Phone: 877-749-7428 Fax: 512-628-3314 | |
Laura Gruber, M.D. Physical Medicine & Rehabilitation Medicare: May Accept Medicare Assignments Practice Location: 785 Mamaroneck Ave, White Plains, NY 10605 Phone: 914-597-2502 | |
Elizabeth Kerrigan, DPT, PT Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 785 Mamaroneck Ave, White Plains, NY 10605 Phone: 914-597-2122 | |
Dr. Syed S Rahman, M.D. Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 1133 Westchester Avenue, N008, White Plains, NY 10604 Phone: 914-358-9700 Fax: 914-696-3609 | |
Dr. Lyle W F Posecion, M.D. Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 4 Westchester Park Dr Ste 325, White Plains, NY 10604 Phone: 914-948-7400 Fax: 914-948-5171 | |
Krina A Vyas, M.D. Physical Medicine & Rehabilitation Medicare: Medicare Enrolled Practice Location: 1133 Westchester Ave, White Plains, NY 10604 Phone: 914-821-9311 |